S 898
117th Congress
Senate
Health
Business records
Civil actions and liability
Congressional oversight
Consumer affairs
Corporate finance and management
Government information and archives
Government studies and investigations
Health care costs and insurance
Inflation and prices
Manufacturing
Marketing and advertising
Medical research
Prescription drugs
Research and development
Fair Accountability and Innovative Research Drug Pricing Act of 2021
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 23, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 23, 2021
Introduced in Senate
Plain-English summary
Fair Accountability and Innovative Research Drug Pricing Act of 2021
This bill requires manufacturers to report about certain price increases for prescription drugs and biological products with a wholesale cost of at least $100 per month. Such reports must include, among other information (1) the percentage price increase, (2) a justification for such increase, (3) the price history of the drug, (4) the total cost to develop the drug, and (5) the total revenue and net profit generated from the drug.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committees of jurisdiction
1